Virilab SA
Virilab reported total assets of 129,924 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Aug 2026).
The score of Virilab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +719 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Virilab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 07 Aug 2024
- Year ended 31 Dec 2022filed on 10 May 2023
- Year ended 31 Dec 2021filed on 25 May 2022
Virilab's financial analysis
- Solvency83.2%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Virilab
Virilab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0434.878.615
- VAT number
- BE0434878615
- Peppol
- Registered · 0208:0434878615 · as of 11 Nov 2026
- Legal form
- SA
- Incorporated
- 15 Jul 1988
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Virilab (SA) has been based in Ixelles since 1988, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 5,732 € and equity of 108,114 €; its revenue is not published. Its solvency stands at 83.2%, above the median of its sector (32.3%).
Companies similar to Virilab
Companies in the same business, of comparable size and area, outside its group.
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- AlphaCare Wholesale of pharmaceutical and medical goods Grez-Doiceau · balance sheet 559,557 €
- Green 2 Manufacture of basic pharmaceutical products Ostend · balance sheet €2.01m
- Linden API Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 12,520 €
- Galenus Inc. Wholesale of pharmaceutical and medical goods Olen · balance sheet 126,374 €
- Labman Wholesale of pharmaceutical and medical goods Torhout · balance sheet 102,667 €
- ELIN Wholesale of pharmaceutical and medical goods Herk-de-Stad · balance sheet 181,098 €
- AM4Dentists Wholesale of pharmaceutical and medical goods Ostend · balance sheet 116,737 €
Frequently asked questions about Virilab
What is the revenue of Virilab?
Virilab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Virilab?
In Belgium, the VAT number is the company number prefixed with BE: BE0434878615 for Virilab, if the company is VAT-registered. Its company number (CBE) is 0434.878.615.
Where is the registered office of Virilab?
According to the CBE register, the registered office of Virilab is in 1050 Ixelles.
What is the equity of Virilab?
At the close of the 2025 financial year, the equity of Virilab amounts to 108,114 €, a solvency of 83.2% of total assets.
Who manages Virilab?
The register lists 4 active mandates at Virilab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Virilab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →